Creative Biolabs

Targeting Delivery for Biomedical Field

The biomedical field is undergoing a profound transformation driven by targeted delivery technology. From new drug development to disease diagnosis, the core challenge lies in how to safely, efficiently, and specifically deliver active substances to their targets. Creative Biolabs' targeted delivery technology focuses on the engineering of nanocarriers, providing innovative solutions for biomedical research and industrialization, from gene therapy to precision diagnostics.

Click Here to View more about our Service

What is Targeted Delivery?

In the biomedical field, "targeted delivery" is a key element in achieving precision medicine. It refers to a sophisticated delivery mechanism centered on three core capabilities: biological barrier penetration, which helps therapeutic payloads, especially macromolecules, bypass dense barriers like the blood-brain barrier (BBB) to reach previously inaccessible disease sites; cell/tissue specificity, which utilizes active targeting ligands (like folate) to ensure high concentrations of therapeutic agents only in diseased tissues, thereby improving the therapeutic window; and spatiotemporal release control, which implements dual-stimuli responsive mechanisms (e.g., pH/temperature sensitivity) to achieve precise and controllable drug release at specific time points or microenvironments.

Applications for the Biomedical Field

Our modern delivery platform extends across the entire spectrum of biomedical innovation, fully supporting the development and optimization of next-generation therapies, diagnostics, and integrated systems.

Therapeutics

Specialized delivery systems are engineered for emerging therapies, including advanced gene and cell therapy products, ensuring nuclear or cytosolic localization.

Drug Delivery

Comprehensive optimization services for traditional small molecule drugs, peptides and proteins, enhancing pharmacokinetics and therapeutic efficacy (e.g., re-formulating existing blockbusters).

Artificial Cells

Novel construction of biomimetic delivery agents, including integrated diagnostic and therapeutic (theranostic) systems.

Marker Detection

Targeted delivery and signal amplification of contrast agents and diagnostic probes, enabling high-resolution imaging and early disease detection.

Cell-Free Protein Synthesis

Targeted delivery of specialized biochemical components and genetic templates to enable robust, decentralized protein production outside of living cellular environments.

Drug delivery and biomedical applications of polysaccharides. (OA Literature)Fig.1 Schematic of polysaccharide based drug delivery.1

Delivery Challenges in the Biomedical Field

What We Can Offer

We offer professional targeted delivery technologies, focusing on solving barrier penetration, stability, and functionality challenges in the biomedical field:

Multifunctional Nanodelivery Platform

Customized delivery systems utilizing LNPs, cutting-edge polymer nanoparticles (including PLGA-PEG), liposomes, etc. This platform achieves stable and efficient encapsulation of all types of payloads, from nucleic acids and proteins to small molecules, ready for in vivo application.

Biological Barrier Penetration Technology

Focused on developing specialized BBB crossing carriers and advanced tumor matrix penetration carriers, ensuring that drugs reach traditionally difficult-to-access sites.

Targeted Functional Carrier Engineering

Surface modification using tumor-specific receptor ligands (like Folate), integration of pH- and temperature-sensitive materials (our "Smart Delivery" expertise), and construction of novel self-assembling biomimetic systems to achieve precise intracellular and subcellular targeting.

Safety and CMC Support

Providing standard-compliant carrier materials and optimizing CMC processes to accelerate clinical translation and market entry with full regulatory confidence. We specialize in enhancing the delivery of existing complex API portfolios.

In-depth Exploration: Our Biomedical Sub-sectors

Click the headings below to explore our advanced delivery solutions in specific biomedical modalities:

Therapeutics

Innovative delivery systems for genes, cells, and biomolecules.

Drug delivery

Optimized targeted delivery and pharmacokinetic/pharmacodynamic (PK/PD) of small molecule and traditional drugs.

Artificial Cells

Constructing biomimetic vectors and integrated diagnostic and therapeutic systems.

Marker Detection

Enhanced targeted delivery of diagnostic probes and contrast agents.

Cell-Free Protein Synthesis

Advanced delivery of molecular machinery for decentralized, off-grid protein production.

Why Choose Us?

Integrated Delivery Science

We offer a validated, integrated approach combining Active Targeting with proprietary Dual-Stimuli Responsive ("Smart Delivery") technology.

Precision and Safety

Our Smart Delivery platform is a proven method for maximizing therapeutic efficacy and minimizing systemic toxicity, demonstrated through successful precision oncology case studies.

Deep Expertise

We bring decades of specialized experience in nanocarrier engineering and clinical translation.

Accelerated Optimization

We leverage advanced computational design to enable rapid carrier optimization and iteration.

Workflow

Service workflow at Creative Biolabs. (Creative Biolabs Original)

Ready to transform your therapeutic concept into a precision medicine reality? Contact our translational science team today for a confidential consultation.

Reference

  1. Salave, Sagar, et al. "Polysaccharide based implantable drug delivery: Development strategies, regulatory requirements, and future perspectives." Polysaccharides 3.3 (2022): 625-654. Distributed under Open Access license CC BY 4.0, without modification. https://doi.org/10.3390/polysaccharides3030037
Our services are For Research Use Only. We do not provide services to individuals.
Online Inquiry

Customer Review

Creatibe Biolabs' custom LNP was the only solution that successfully delivered our CRISPR-Cas9 payload across the blood-brain barrier with high efficiency and low toxicity.”

Dr. Evelyn Reed

Postdoctoral Researcher, Leading University

Our siRNA candidate was failing due to off-target toxicity, but Creatibe Biolabs' team rapidly redesigned our LNP using their modular platform, rescuing our preclinical program.”

Ben Carter

Project Manager

Achieving cytosolic delivery of our protein degrader with Creatibe Biolabs' exosome platform was the key to unlocking our candidate's full therapeutic potential.”

Dr. Kenji Tanaka

Principal Scientist, Large Pharma Corp

Our oncology drug's efficacy was limited by poor tumor accumulation. Creatibe Biolabs' peptide-conjugated liposomes provided the precise targeting we needed, dramatically increasing the drug's therapeutic index.”

Dr. Clara Schmidt

Senior Scientist, Oncology Innovations Inc.

We required a delivery system that would only release its payload in the tumor's acidic microenvironment. Creatibe Biolabs' pH-responsive liposomes performed flawlessly, minimizing systemic exposure.”

David Chen

Formulation Scientist

Outstanding expertise in antibody engineering.The team's attention to detail and innovative approaches have sianificantly accelerated our development timeline.

Sarah L.

Senior Research Scientist

Contact us for more information Get free consultations
ad